LRTM2 Antikörper (C-Term)
Kurzübersicht für LRTM2 Antikörper (C-Term) (ABIN953240)
Target
Alle LRTM2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 346-370, C-Term
-
Spezifität
- This antibody recognizes Human LRTM2 (C-term).
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 346-370 amino acids from the C-terminal region of human LRTM2
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- LRTM2 (Leucine-Rich Repeats and Transmembrane Domains 2 (LRTM2))
-
Andere Bezeichnung
- LRTM2
-
Hintergrund
- Synonyms: Leucine-rich repeat and transmembrane domain-containing protein 2
-
Molekulargewicht
- 41158 Da
-
Gen-ID
- 654429
-
NCBI Accession
- NP_001034118
Target
-